721 results on '"O’Donnell, Denis E."'
Search Results
2. Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation
3. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study
4. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
5. V̇/Q̇ Mismatch: A Novel Target for COPD Treatment
6. Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory Disease
7. Compensatory responses to increased mechanical abnormalities in COPD during sleep
8. Exercise Intolerance in Untreated OSA: Role of Pulmonary Gas Exchange and Systemic Vascular Abnormalities
9. Multidimensional breathlessness response to exercise: Impact of COPD and healthy ageing
10. Influence of exertional hypoxemia on cerebral oxygenation in fibrotic interstitial lung disease
11. Elevated exercise ventilation in mild COPD is not linked to enhanced central chemosensitivity
12. Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl
13. The Lung Function Laboratory to Assist Clinical Decision-making in Pulmonology: Evolving Challenges to an Old Issue
14. Breathing at Extremes: The Restrictive Consequences of Super- and Super-Super Obesity in Men and Women
15. Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance.
16. Reference values for leg effort during incremental cycle ergometry in non‐trained healthy men and women, aged 19–85.
17. Physiological and perceptual responses to exercise according to locus of symptom limitation in COPD
18. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study
19. Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD
20. Dyspnea in COPD: New Mechanistic Insights and Management Implications
21. Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
22. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio?
23. Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study
24. Systemic vascular dysfunction is associated with emphysema burden in mild COPD
25. The role of the pulmonary function laboratory to assist in disease management: connective tissue diseases.
26. Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis
27. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
28. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO.
29. Short- term air pollution exposure and exacerbation events in mild to moderate COPD: a case- crossover study within the CanCOLD cohort.
30. Online Data Supplement: Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
31. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
32. Heart, lungs, and muscle interplay in worsening activity-related breathlessness in advanced cardiopulmonary disease
33. Physiological and sensory consequences of exercise oscillatory ventilation in heart failure-COPD
34. The COPD Assessment Test: Can It Discriminate Across COPD Subpopulations?
35. Adverse cardiac events associated with incident opioid drug use among older adults with COPD
36. Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study
37. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study.
38. Pulmonary function laboratory to assist in the management of cardiac disease.
39. Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
40. Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
41. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD
42. Neurophysiological mechanisms of exertional dyspnea in post-pulmonary embolism syndrome.
43. Pulmonary Vascular Volume by Quantitative CT in Dyspneic Smokers with Minor Emphysema.
44. Exercise Intolerance in Untreated OSA: Role of Pulmonary Gas Exchange and Systemic Vascular Abnormalities.
45. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
46. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD
47. Effects of BMI on Static Lung Volumes in Patients With Airway Obstruction
48. Recent advances in pharmacotherapy for dyspnea in COPD
49. The severe asthma–obesity conundrum: Consequences for exertional dyspnoea and exercise tolerance in men and women.
50. Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.